Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.13.20 extracted from

  • Balion, C.M.; Benson, C.; Raina, P.S.; Papaioannou, A.; Patterson, C.; Ismaila, A.S.
    Brain type carnosinase in dementia: a pilot study (2007), BMC Neurol., 7, 38.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine study on carnosinase activity in patients with Alzheimer's disease and with mixed dementia. Enzyme activity levels in the mixed disease group are significantly lower than the Alzheimer's disease group and the mixed disease group demonstrates a significant trend with carnosidase activity decreasing with duration of disease. Both Alzheimer and mixed disease patients on any demetia medication have higher carnosinase activity compared to those not taking a dementia medication, and enzyme activity is higher in patients who regurlarly exercise compared to those who do not exercise regurlarly Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
patients with Alzheimer's disease and with mixed dementia
-